Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3770266014 | Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| 3770267017 | Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has manufactured dose form | Conventional release oromucosal solution | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength denominator unit | Milliliter | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Is a | Product containing only anthraquinone glycoside and salicylic acid in oromucosal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has precise active ingredient | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has precise active ingredient | Anthraquinone glycoside | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has basis of strength substance | Anthraquinone glycoside | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has basis of strength substance | Salicylic acid | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength numerator value | 5 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Has concentration strength numerator value | 10 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely anthraquinone glycoside 5 milligram/1 milliliter and salicylic acid 10 milligram/1 milliliter conventional release oromucosal solution (clinical drug) | Plays role | Antifungal therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR